MDS PODCAST: Defining Parkinson’s disease

Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders.

Subscribe

MDS Podcast A post-hoc analysis of the Prasinezumab trial in early Parkinson’s disease

15 de julio de 2024 casimedicos MDS PODCAST: Defining Parkinson's disease 0 Comments

Dr. Gennaro Pagano discusses the findings of the post-hoc analysis of the PASADENA trial, a study using the monoclonal antibody Prasinezumab directed at aggregated α-synuclein, where motor progression trajectories differed between active and placebo groups. Read article »

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.